期刊文献+

脑利钠肽不同停药方法对急性前壁心肌梗死合并心力衰竭患者临床疗效观察 被引量:7

The Clinical Efficacy of Different Methods of Stopping Brain Natriuretic Peptide in Patients with Acute Anterior Myocardial Infarction Complicated with Heart Failure
下载PDF
导出
摘要 目的观察脑利钠肽(brain natriuretic peptide,NT- proBNP)逐渐减量停药与突然停药对急性前壁心肌梗死合并心力衰竭临床疗效是否存在差异。方法入选我院2017年1月至2017年12月收治的急性前壁心肌梗死合并心力衰竭患者38例,均予以脑利钠肽泵入,随机分为逐渐减量停药组20例及突然停药对照组18例,测定NT- ProBNP水平,行心脏彩超检查测定左室射血分数,并观察停药后患者心力衰竭控制情况。结果两组患者NT- ProBNP水平及左心室射血分数均有所改善,但逐渐减量停药组患者心力衰竭控制情况优于对照组,且两组之间差异具有统计学意义( P <0.05)。结论急性前壁心肌梗死合并心力衰竭患者在应用脑利钠肽改善心功能、减低心脏负荷治疗时可考虑逐渐减量停药以避免心衰反复而尽量避免突然停药。 Objective To observe the potential different clinical efficacies of acute anterior myocardial infarction complicated by heart failure with gradual withdrawal of brain natriuretic peptide versus acute withdrawal. Methods 38 patients enrolled in our hospital from January,2017 to December,2017 with acute anterior myocardial infarction complicated by heart failure were randomly divided into two groups:the progressive reduction group (n=20)and the control group(n=18).Clinical symptoms were observed and NT- ProBNP and LVEF were meaured. Results NT- ProBNP and left ventricular ejection fraction were improved in both groups,but the progressive reduction group was better than the control group in the control of heart failure symptoms( P <0.05). Conclusion Patients with acute anterior myocardial infarction complicated with heart failure should have a gradual reduction of the dose of brain natriuretic peptide.
作者 任岩春 赵永峰 张晓蕾 王硕 董静杰 杨艳 张莹洁 REN Yan-chun;ZHAO Yong-feng;ZHANG Xiao-lei;WANG Shuo;DONG Jing-jie;ZHANG Yingjie(Department of Cardiology,First Hospital of Shijiazhuang,Shijiazhuang 050011,China)
出处 《标记免疫分析与临床》 CAS 2019年第8期1343-1345,共3页 Labeled Immunoassays and Clinical Medicine
基金 石家庄市科学技术研究发展指导计划(编号:161462493)
关键词 脑利钠肽 急性前壁心肌梗死 心力衰竭 NT- PROBNP 左室射血分数 Brain natriuretic peptide Acute anterior myocardial infarction Heart failure NT- ProBNP Left ventricular ejection fraction
  • 相关文献

参考文献5

二级参考文献59

  • 1史晓敏,林箐,徐国宾,宋以信,夏铁安.血清N末端B型钠尿肽原在心功能评价及慢性充血性心力衰竭诊断中的初步应用[J].中华检验医学杂志,2005,28(1):37-41. 被引量:77
  • 2谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 3马虹.重组人B型利钠肽治疗急性失代偿性心力衰竭[J].中华老年心脑血管病杂志,2006,8(4):217-218. 被引量:13
  • 4中华医学会心血管病学分会 中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗建议.中华心血管病杂志,2007,35(12):1076-1095.
  • 5Mccullough PA.Clinical applications of B-type natriuretic peptide levels in the care of cardiovascular patients.Minerva Cardioangiol,2004,52:479-489.
  • 6Sudoh T,Kangawa K,Minamino N,et al.A natriuretic peptide in porcine brain.Nature,1998,332:78-81.
  • 7Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF).Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure:a randomized controlled trial.JAMA,2002,287:1531-1540.
  • 8Yancy CW,Singh A.Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide[FUSION Ⅰ] trial).Am J Cardiol,2006,98:226-229.
  • 9Yancy CW,Krum H,Massie BM,et al.The Second Follow-up Serial Infusions of Nesiritide (FUSION Ⅱ) trial for advanced heart failure:study rationale and design.Am Heart J,2007,153:478-484.
  • 10中华医学会心血管病学分会 中华心血管病杂志编辑委员会.中国急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38:195-208.

共引文献199

同被引文献76

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部